Line 95:
Line 95:
|-
|-
|1
|1
−
|A clinical study of Nirgundi Ghana Vati & matra basti in the management of Gridhrasi w.s.r. to Sciatica. <sup>[8]</sup>
+
|A clinical study of Nirgundi Ghana Vati & matra basti in the management of Gridhrasi w.s.r. to Sciatica.<ref name="ref8">Ali M, Shukla VD, Dave AR, Bhatt NN. A clinical study of Nirgundi Ghana Vati and Matra Basti in the management of Gridhrasi with special reference to sciatica. Ayu. 2010 Oct;31(4):456-60. doi: 10.4103/0974-8520.82042. PMID: 22048539; PMCID: PMC3202251.</ref>
|Mumtaz Ali, V D Shukla, A R Dave, N N Bhatt
|Mumtaz Ali, V D Shukla, A R Dave, N N Bhatt
|Outpatients and inpatients of Kayachikitsa and Panchakarma Department, Institute of post graduate teaching and research in Ayurveda, Jamnagar
|Outpatients and inpatients of Kayachikitsa and Panchakarma Department, Institute of post graduate teaching and research in Ayurveda, Jamnagar
|
|
−
=== 1]mild improvement –group A- 59.52% group B-52% ===
+
# mild improvement –group A- 59.52% group B-52%
−
+
# moderate improvement –group A- 26.8% group B-32%
−
=== 2]moderate improvement –group A- 26.8% group B-32% ===
+
# marked improvement –group A- 13.44% group B-18%
−
−
=== 3]marked improvement –group A- 13.44% group B-18% ===
|In this research, total 119 patients diagnosed with sciatica. Better results were obtained in patients who underwent matra basti rather than Nirgundi Ghan alone.
|In this research, total 119 patients diagnosed with sciatica. Better results were obtained in patients who underwent matra basti rather than Nirgundi Ghan alone.
|-
|-
|2
|2
−
|
+
|Clinical effect of Matra Basti and Vatari Guggulu in the management of Amavata (rheumatoid arthritis).<ref name="ref9">Khagram R, Mehta CS, Shukla VD, Dave AR. Clinical effect of Matra Basti and Vatari Guggulu in the management of Amavata (rheumatoid arthritis). Ayu. 2010 Jul;31(3):343-50. doi: 10.4103/0974-8520.77167. PMID: 22131737; PMCID: PMC3221069.</ref>
−
= Clinical effect of Matra Basti and Vatari Guggulu in the management of Amavata (rheumatoid arthritis).'''<sup>[9]</sup>''' =
|Rita Khagram Charmi S Mehta, V D Shukla, Alankruta R Dave
|Rita Khagram Charmi S Mehta, V D Shukla, Alankruta R Dave
|OPD and IPD Kayachikitsa and Panchakarma Department, Institute of post graduate teaching and research in Ayurveda, Jamnagar
|OPD and IPD Kayachikitsa and Panchakarma Department, Institute of post graduate teaching and research in Ayurveda, Jamnagar
−
|In ''Matra Basti'' group, 52%; 26 patients showed marked improvement, while in the ''Vatari Guggulu'' group 54.72%; 29 patients showed mild improvement.
+
|In Matra Basti group, 52%; 26 patients showed marked improvement, while in the Vatari Guggulu group 54.72%; 29 patients showed mild improvement.
−
|
+
|Total 103 patients completed the treatment for Amavata. Better results were obtained in patients who underwent Matra Basti rather than Vatari Guggulu alone.
−
=== Total 103 patients completed the treatment for Amavata. Better results were obtained in patients who underwent Matra Basti rather than Vatari Guggulu alone. ===
|-
|-
|3
|3
−
|A clinical evaluation of Kanchanar Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia. <sup>[10]</sup>
+
|A clinical evaluation of Kanchanar Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia.<ref name="ref10">Banothe GD, Mahanta V, Gupta SK, Dudhamal TS. A clinical evaluation of Kanchanara Guggulu and Bala Taila Matra Basti in the management of Mutraghata with special reference to benign prostatic hyperplasia. Ayu. 2018 Apr-Jun;39(2):65-71. doi: 10.4103/ayu.AYU_117_15. PMID: 30783359; PMCID: PMC6369605.</ref>
−
|
+
|Gajiram Dharamdas
−
=== Gajiram Dharamdas ===
+
Banothe , Vyasdeva Mahanta, Sanjay Kumar Gupta, Tukaram S Dudhamal
−
Banothe , Vyasdeva Mahanta <sup>,</sup> Sanjay Kumar Gupta , Tukaram S Dudhamal
|IPGT & RA department of Shalya tantra, Jamnagar.
|IPGT & RA department of Shalya tantra, Jamnagar.
−
|Group A- ''Bala Taila'' ''Matra Basti'',
+
|Group A- Bala Taila Matra Basti,
−
+
Group B- Bala Taila Matra Basti, and Kanchanara Guggulu Vati administered for 21 days.
−
Group B- ''Bala Taila'' ''Matra Basti'', and ''Kanchanara Guggulu'' Vati administered for 21 days.
|Total 32 patients were participated in this study.
|Total 32 patients were participated in this study.
−
+
Matra basti along with Kanchanara Guggulu orally showed comparatively better symptomatic relief as compared to Matra Basti alone in cases of Mutraghata (BPH).
−
''Matra basti'' along with ''Kanchanara Guggulu'' orally showed comparatively better symptomatic relief as compared to ''Matra Basti'' alone in cases of ''Mutraghata'' (BPH).
|-
|-
|4
|4
−
|
+
|Efficacy of Kanchanara Guggulu and Matra Basti of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia).<ref name="ref11">Patel JK, Dudhamal TS, Gupta SK, Mahanta V. Efficacy of Kanchanara Guggulu and Matra Basti of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia). Ayu. 2015 Apr-Jun;36(2):138-44. doi: 10.4103/0974-8520.175552. PMID: 27011713; PMCID: PMC4784122.</ref>
−
= Efficacy of Kanchanara Guggulu and Matra Basti of Dhanyaka Gokshura Ghrita in Mootraghata (benign prostatic hyperplasia). =
−
'''<sup>[11]</sup>'''
|Joyal Kumar K Patel , Tukaram S Dudhamal, Sanjay Kumar Gupta, Vyasadeva Mahanta
|Joyal Kumar K Patel , Tukaram S Dudhamal, Sanjay Kumar Gupta, Vyasadeva Mahanta
|OPD and IPD of Shalya Tantra, Jamnagar.
|OPD and IPD of Shalya Tantra, Jamnagar.
|Group A- Kanchanara Guggulu (500 mg, 3 times a day orally),
|Group A- Kanchanara Guggulu (500 mg, 3 times a day orally),
−
Group B- Dhanyaka Gokshura Ghrita Matra Basti,
Group B- Dhanyaka Gokshura Ghrita Matra Basti,
−
Group C- Kanchanara Guggulu + Dhanyaka Gokshura Ghrita Matra Basti for 21 days.
Group C- Kanchanara Guggulu + Dhanyaka Gokshura Ghrita Matra Basti for 21 days.
−
+
# Maximum improvement- 33.34%, 55.56% and 33.34% of patients in Group A, Group B and Group C, respectively.
−
1)Maximum improvement- 33.34%, 55.56% and 33.34% of patients in Group A, Group B and Group C, respectively.
+
# Moderate improvement- 44.44% of patients in all three groups.
−
+
# The mild improvement -11.11% and 22.22% in Group A and Group C, respectively
−
2)Moderate improvement- 44.44% of patients in all three groups.
−
−
3)The mild improvement -11.11% and 22.22% in Group A and Group C, respectively
|Total 30 diagnosed patients of BPH were selected. They underwent intervention and found maximum imrprovement with Matra Basti
|Total 30 diagnosed patients of BPH were selected. They underwent intervention and found maximum imrprovement with Matra Basti
|-
|-
|5
|5
−
|
+
|Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of Benign Prostatic Hyperplasia.<ref name="ref12">Bhalodia SG, Bhuyan C, Gupta SK, Dudhamal TS. Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of Benign Prostatic Hyperplasia. Ayu. 2012 Oct;33(4):547-51. doi: 10.4103/0974-8520.110532. PMID: 23723674; PMCID: PMC3665207.</ref>
−
= Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of Benign Prostatic Hyperplasia. '''<sup>[12]</sup>''' =
+
|Shreyas G Bhalodia, Chaturbhuj Bhuyan, Sanjay Kumar Gupta, Tukaram S Dudhamal
−
−
−
|Shreyas G Bhalodia , Chaturbhuj Bhuyan , Sanjay Kumar Gupta, Tukaram S Dudhamal
|OPD and IPD of Shalya Tantra, Jamnagar.
|OPD and IPD of Shalya Tantra, Jamnagar.
−
|
+
|10 in each group, 21 days of treatment regimen
−
=== 10 in each group, 21 days of treatment regimen ===
+
Group A-Gokshuradi compound Vati 500 mg three times a day with luke-warm water after food;
−
+
Group B- Dhanyaka-Gokshura Ghrita as Matra Basti of 60 ml, once in a day, and combined therapy of both formulations in
−
=== Group A-''Gokshuradi'' compound ''Vati'' 500 mg three times a day with luke-warm water after food; ===
+
Group C- Gokshuradi compound Vati + Dhanyaka-Gokshura Ghrita as Matra Basti of 60 ml was administered.
−
−
=== Group B- ''Dhanyaka-Gokshura Ghrita'' as ''Matra Basti'' of 60 ml, once in a day, and combined therapy of both formulations in ===
−
−
=== Group C- ''Gokshuradi'' compound ''Vati'' + ''Dhanyaka-Gokshura Ghrita'' as ''Matra Basti'' of 60 ml was administered. ===
45.67% improvement was seen in group A, 47.99% in group B, and 54.09% was seen in group C. The size of prostate gland was found reduced highly significant in group C.
45.67% improvement was seen in group A, 47.99% in group B, and 54.09% was seen in group C. The size of prostate gland was found reduced highly significant in group C.
|Maximum improvement was found in the Matra Basti group.
|Maximum improvement was found in the Matra Basti group.
|-
|-
|6
|6
−
|A comparative study of Dashamoola Taila Matra Basti and Tila Taila Matra Basti in Kashtartava (dysmenorrhea). '''<sup>[13]</sup>'''
+
|A comparative study of Dashamoola Taila Matra Basti and Tila Taila Matra Basti in Kashtartava (dysmenorrhea). <ref name="ref13">Karunagoda K, Shukla Upadhyaya K, Donga S, Tanna C, Dei LP. A comparative study of Dashamoola Taila Matra Basti and Tila Taila Matra Basti in Kashtartava (dysmenorrhea). Ayu. 2010 Jul;31(3):305-10. doi: 10.4103/0974-8520.77154. PMID: 22131731; PMCID: PMC3221063.</ref>
|Kaumadi Karunagoda , Kamayani Shukla Upadhyaya, Shilpa Donga, Chandrika Tanna, L P Dei
|Kaumadi Karunagoda , Kamayani Shukla Upadhyaya, Shilpa Donga, Chandrika Tanna, L P Dei
|Department of Striroga and Prasuti Tantra, IPGT and RA, Gujarat Ayurved University, Jamnagar.
|Department of Striroga and Prasuti Tantra, IPGT and RA, Gujarat Ayurved University, Jamnagar.
−
|
+
|For the present study, only primary dysmenorrhea was considered under Kashtartava.
−
=== For the present study, only primary dysmenorrhea was considered under ''Kashtartava''. ===
+
|Tila taila matra basti and dashamoola taila matra basti are both highly effective in primary dysmenorrhea (kashtartava). Dashamoola Taila Matra Basti also helps to prevent recurrence of dysmenorrhea.
−
|''Tila taila matra basti'' and ''dashamoola taila matra basti'' are both highly effective in primary dysmenorrhea ''(kashtartava). Dashamoola Taila Matra Basti'' also helps to prevent recurrence of dysmenorrhea.
|-
|-
|7
|7
−
|
+
|Role of Nasya and Matra Basti with Narayana Taila on anovulatory factor.<ref name="ref14">Donga KR, Donga SB, Dei LP. Role of Nasya and Matra Basti with Narayana Taila on anovulatory factor. Ayu. 2013 Jan;34(1):81-5. doi: 10.4103/0974-8520.115453. PMID: 24049410; PMCID: PMC3764886.</ref>
−
= Role of Nasya and Matra Basti with Narayana Taila on anovulatory factor. '''<sup>[14]</sup>''' =
|Krupa R Donga , Shilpa B Donga, Laxmi Priya Dei
|Krupa R Donga , Shilpa B Donga, Laxmi Priya Dei
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
−
|''22 patients were completed the study (11 in each group).''
+
|22 patients were completed the study (11 in each group).
−
|''Matra Basti'' provides significant results over ''Nasya'' on anovulatory factor.
+
|Matra Basti provides significant results over Nasya on anovulatory factor.
|-
|-
|8
|8
−
|Effect of shatapushpa taila matra basti and pathadi kwatha on poly cystic ovarian disease. '''<sup>[15]</sup>'''
+
|Effect of shatapushpa taila matra basti and pathadi kwatha on poly cystic ovarian disease.<ref name="ref15">Patel KD, Dei L, Donga SB, Anand N. Effect of shatapushpa taila matra basti and pathadi kwatha on poly cystic ovarian disease. Ayu. 2012 Apr;33(2):243-6. doi: 10.4103/0974-8520.105245. PMID: 23559797; PMCID: PMC3611647.</ref>
|Krupa D Patel , Laxmipriya Dei, Shilpa B Donga, Nalini Anand
|Krupa D Patel , Laxmipriya Dei, Shilpa B Donga, Nalini Anand
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
|OPD/IPD of S.R.P.T. Dept, I.P.G.T & R.A Jamnagar,2014.
−
|Group 1- 14 patients (''Pathadi Kwatha Churna)''
+
|Group 1- 14 patients (Pathadi Kwatha Churna)
−
Group 2- 12 patients shatapushpa taila matra basti (STMB)
Group 2- 12 patients shatapushpa taila matra basti (STMB)
−
Group 2 provided statistically better results in regularizing menstruation, achieving considerable reduction in body weight, substantial growth of follicles, and thus ovulation.
Group 2 provided statistically better results in regularizing menstruation, achieving considerable reduction in body weight, substantial growth of follicles, and thus ovulation.
−
|Treatment with the combination of both ''Pathadi Kwatha'' and Matra Basti has additional effect on the symptoms of PCOD.
+
|Treatment with the combination of both Pathadi Kwatha and Matra Basti has additional effect on the symptoms of PCOD.
|}
|}